Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects

International Journal of Obesity

Volumn 21, Issue 11, 1997, Pages 972-979

  Van Harmelen, V ^a   Lonnqvist F ^a   Thorne A ^a   Wennlund, A ^a   Large, V ^a   Reynisdottir, S ^a   Arner, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adipocyte tissue heterogeneity; Lipolysis; adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; DOBUTAMINE; GLYCEROL; ISOPRENALINE; NORADRENALIN; RECEPTOR SUBTYPE; TERBUTALINE; YOHIMBINE;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIPID STORAGE; LIPOLYSIS; MALE; MESENTERY; OBESITY; OMENTUM; PRIORITY JOURNAL; SUBCUTANEOUS FAT; VISCERA;

EID: 0030817726     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800504     Document Type: Article

References (25)

1. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993; 34: 1057-1092.
2. Arner P. Regulation of lipolysis in fat cells. Diab Rev 1997; (in press).
3. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Am Physiol Soc 1994; 74: 761-811.
4. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Annals of Medicine 1995; 27: 435-438.
5. Rebuffé-Scrive M, Andersson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots of non obese men and women. Metabolism 1989; 38(5): 453-458.
6. Rebuffé-Scrive M, Anderson A, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 1990; 39(10): 1021-1025.
7. Mauriège P, Marette A, Atgié C, Bouchard C, Thériault G, Bukowiecki LK, Marceau P, Biron S, Nadeau A, Després JP. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res 1995; 36: 672-684.
8. Large V, Reynisdottir S, Eleborg L, Van Harmelen V, Strömmer L, Arner P. Lipolysis in human fat cells obtained under local and general anesthesia. Int J Obes 1997; 21: 78-82.
9. Rodbell M. Metabolism of isolated fat cells. J Biol Chem 1964; 239: 375-380.
10. Di Girolamo M, Mendlinger S, Fertig JW. A simple method to determine fat cell size and number in four mammalian species. Am J Physiol 1971; 221: 850-858.
11. Hirsch J, Gallian E. Methods for determination of adipose cell size in man and animals. J Lipid Res 1968; 9: 110-119.
12. Arner P, Bounder J, Hellmér J, Engfeldt P. Studies on human fat cell metabolism in small adipose tissue samples. In: Clarke WL, Larner, J, Pohl SL (eds), Methods in Diabetes Research. J Wiley & Sons: New York, 1986, pp 233-258
13. Hellmér J, Arner P, Lundin A. Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem 1989; 177: 132-137.
14. Kenakin T. The classification of drugs and drug receptors in isolated tissue. Pharmacol Rev 1984; 36: 165-214.
15. Lönnqvist F, Wahrenberg H, Hellström L, Reynisdottir S, Arner P. Lipolytic catecholamine resistance due to decreased β2-adrenoceptor expression in fat cells. J Clin Invest 1992; 90: 2175-2186.
16. Fried SK, Kral JG. Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int J Obes 1987; 11: 129-140.
17. Vikman HL, Ohisalo JJ. Regulation of adenylate cyclase in plasma membranes of human intraabdominal and abdominal subcutaneous adipocytes. Metabolism 1993; 6: 739-742.
18. Lönnqvist F, Krief S, Strosberg AD, Nyberg B, Emorine LJ, Arner P. Evidence for a functional β3-adrenoceptor in man. Br J Pharmacol 1993; 110: 929-936.
19. Hoffstedt J, Lönnqvist F, Shimizu M, Blaak E, Arner P. Effects of several putative β3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int J Obes 1996; 20(5): 428-434.
20. Deng CJ, Paoloni-Giacobino A, Kuehne F, Boss O, Revelli JP, Moinat M, Cawthorne MA, Muzzin P, Giacobino JP. Respective degree of expression of beta(1)-, beta(2)- and beta(3)-adrenoceptors in human brown and white adipose tissue. Br J Pharmacol 1996; 118(4): 929-934.
21. Tavernier G, Barbe P, Galitzky J, Berlan M, Caput D, Lafontan M, Langin D. Expression of β3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipis Res 1996; 37: 87-97.
22. Hoffstedt J, Shimizu M, Sjöstedt S, Lönnqvist F. Determination of β3-adrenoceptor mediated lipolysis in human fat cells. Obes Res 1995; 3(5): 447-457.
23. Enocksson S, Shimizu M, Lönnqvist F, Nordenström J, Arner P. Demonstration of an in vivo functional β3-adrenoceptor in man. J Clin Invest 1995; 95(5): 2239-2245.
24. Shimizu M, Blaak EE, Lönnqvist F, Gåfvels ME, Arner P. Agonist and antagonist properties of β3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes. Pharmacol Toxicol 1996; 78: 254-263.
25. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat beta-3 adrenoceptors in obesity. J Clin Invest 1995; 95: 1109-1116.